Population pharmacokinetics of marbofloxacin in aqueous humor after intravenous administration in dogs

American Journal of Veterinary Research

Volumn 64, Issue 7, 2003, Pages 889-893

  Regnier, Alain ^a   Concordet, Didier ^a   Schneider, Marc ^b   Boisrame, Bernard ^b   Toutain, Pierre Louis ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b Vetoquinol SA   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MARBOCYL FD; MARBOFLOXACIN;

ANTERIOR EYE CHAMBER DISEASE; ANTIBIOTIC PROPHYLAXIS; ANTIMICROBIAL ACTIVITY; AQUEOUS HUMOR; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BLOOD SAMPLING; CATARACT EXTRACTION; CONTROLLED STUDY; DISEASE MARKER; DOG; DRUG ADMINISTRATION ROUTE; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG PENETRATION; ENTEROBACTERIACEAE; EYE INFECTION; GROWTH INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; NONHUMAN; NONLINEAR SYSTEM; PHARMACODYNAMICS; PSEUDOMONAS AERUGINOSA; SIMULATION; SINGLE DRUG DOSE; STAPHYLOCOCCUS; STREPTOCOCCUS INFECTION; TIME;

ANIMALS; ANTI-INFECTIVE AGENTS; AQUEOUS HUMOR; DOG DISEASES; DOGS; EYE DISEASES; FEMALE; FLUOROQUINOLONES; HALF-LIFE; INJECTIONS, INTRAVENOUS; MALE; QUINOLONES;

ANIMALIA; BACTERIA (MICROORGANISMS); CANIS FAMILIARIS; ENTEROBACTERIACEAE; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS; STREPTOCOCCUS;

EID: 0037817534     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2003.64.889     Document Type: Article

References (34)

1. Behrens-Baumann W, Martell J. Ciprofloxacin concentrations in human aqueous humor following intravenous administration. Chemotherapy 1987;33:328-330.
2. El Baba FZ, Trouslade MD, Gauderman WJ. Intravitreal penetration of oral ciprofloxacin in humans. Ophthalmology 1992;99:483-480.
3. Giamarellou H, Kanellas D, Kavouklis E, et al. Comparative pharmacokinetics of ciprofloxacm, ofloxacin and pefloxacin in human aqueous humour. Eur J Clin Microbiol Infect Dis 1993,12:293-297.
4. Morlet N, Graham GG, Gatus B, et al. Pharmacokinetics of ciprofloxacin in the human eye: a clinical study and population pharmacokinetic analysis. Antimicrob Agents Chemother 2000;44:1674-1679.
5. von Gunten S, Lew D, Paccolat F. Aqueous humor penetration of ofloxacin given by various routes. Am J Ophthalmol 1994;117:87-89.
6. Donnenfeld ED, Perry HD, Snyder RW, et al. Intracorneal, aqueous humor, and vitreous humor penetration of topical and oral ofloxacin. Arch Ophthalmol 1997;115:173-176.
7. Salvanet A, Fisch A, Lafaix C, et al. Pefloxacin concentrations in human aqueous humour and lens. J Antimicrob Chemother 1986;18:199-201.
8. Bron AM, Pechinot AP, Garcher CP, et al. The ocular penetration of oral sparfloxacin in humans. Am J Ophthalmol 1994;117:322-327.
9. Rowley RA, Rubin LF. Penetration of penicillin into the aqueous humor of the dog. Am J Vet Res 1969;30:1945-1950.
10. Sigel CW, Macklin AW, Grace ME, et al. Trimethoprim and sulfadiazine concentrations in aqueous and vitreous humors of the dog. Vet Med Small Anim Clin 1981;76:991-993.
11. Whelan NC, Richardson RJ, Kinyon JM, et al. Ocular and serum pharmacokinetics of intravenous cefazotin in the dog, in Proceedings. 31th Annu Meet Am Coll Vet Ophthalmol 2000;13.
12. Whelan NC, Richardson RJ, Kinyon JM. Ocular and serum pharmacokinetics of intravenous doxycycline in the dog, in Proceedings. 31th Annu Meet Am Coll Vet Ophthalmol 2000;33.
13. Spreng M, Deleforge J, Thomas V, et al. Antibacterial activity of marbofloxacin. A new fluoroquinolone for veterinary use against canine and feline isolates. J Vet Pharmacol Ther 1995; 18:284-289.
14. von Weber A, Wachowitz R, Fuchs D, et al. Resistenzverhalten von zwei fluochinolonen marbofloxacin und enrofloxacin, un vergleich. Tierärztl Umsch 2000;55:397-401.
15. Cester CC, Schneider M, Toutain PL. Comparative kinetics of two orally administered quinolones in dog: enrofloxacm versus marbofloxacin. Rev Med Vet (Toulouse) 1996;147:703-716.
16. Schneider M, Thomas V, Boisrame B, et al. Pharmacokinetics of marbofloxacin in dogs after oral and parenteral administration. J Vet Pharmacol Ther 1996; 19:56-61.
17. Meredith T. Antibiotics and antifungals. In: Zimmerman TJ, Kooner KS, Sharir M, eds. Textbook of ocular pharmacology. Philadelphia: Lippincott-Raven, 1997;363-385.
18. Schmitz K, Banditt P, Motschmarm M, et al. Population pharmacokinetics of 2% dorzolamide in the aqueous humor of humans. Invest Ophthalmol Vis Sci 1999;40:1621-1624.
19. Gum G. Physiology of the eye. in: Gelatt K, ed. Veterinary ophthalmology. Philadelphia: Lea & Febiger, 1991;124-161.
20. Beal SL, Sheiner LB. Conditional estimation methods. In: Nonmem users guide. Part VII. San Francisco: University of California, 1992.
21. Sanchez-Navarro A, Sanchez Recio MM. Basis of anti-infective therapy: pharmacokinetic-pharmacodynamic criteria and methodology for dual dosage individualisation. Clin Pharmacokinet 1999;37:289-304.
22. Nicolau DP. Using pharmacodynamic and pharmacokinetic surrogate markers in clinical practice: optimizing antimicrobial therapy in respiratory-tract infections. Am J Health Syst Pharm 1999;56 (suppl 3):S16-S20.
23. Dudley MN, Ambrose PG. Pharmacodynamics in the study of drug resistance and establishing in vitro susceptibility breakpoints: ready for prime time. Curr Opin Microbiol 2000;3:515-521.
24. Hyatt JM, McKinnon PS, Zimmer GS, et al. The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome: focus on antibacterial agents. Clin Pharmacokinet 1995;28:143-160.
25. Toutain PL, Delcastillo JRE, Bousquet-Mélou A. The pharmacokinetic-pharmacodynamic approach to a rational dosage regimen for antibiotics. Res Vet Sci 2002;73:105-114.
26. Turnidge J. Pharmacokinetics and pharmacodynamics of fluoroquinolones. Drugs 1999;58(suppl 2):29-36.
27. Riviere JE. Veterinary clinical pharmacokinetics. Part II. Modeling. Compend Cont Educ Pract Vet 1988;10:314-328.
28. Drusano GL, Liu W, Perkins R, et al. Determination of robust ocular pharmacokinetic parameters in serum and vitreous humor of albino rabbits following systemic administration of ciprofloxacin from sparse data sets by using IT2S, a population pharmacokinctic modeling program. Antimicrob Agents Chemother 1995;39:1683-1687.
29. Madu AA, Mayers M, Perkins R, et al. Aqueous and vitreous penetration of ciprofloxacm following different modes of systemic administration. Exp Eye Res 1996;63:129-136.
30. Ward DA, Cawrse MA, Hendrix DV. Fluorophotometric determination of aqueous humor flow rate in clinically normal dogs. Am J Vet Res 2001;62:853-858.
31. Whitley RD. Canine and feline primary ocular bacterial infections. Vet Clin North Am Small Anim Pract 2000;30:1151-1167.
32. Papich MG, Riviere JE. Fluoroquinolone antimicrobial drugs. In: Adams HR, ed. Veterinary pharmacology and therapeutics. 8th ed. Ames, Iowa: Iowa State University Press, 2001;898-917.
33. Öztürk F, Kurt E, inan ÜÜ, et al. Penetration of topical and oral ofloxacin into the aqueous and vitreous humor of inflamed rabbit eyes. Int J Pharm 2000;204:91-95.
34. Cekiç O, Batman C, Yasar U, et al. Subretinal fluid levels of topical, oral, and combined administered ciprofloxacin in humans. Br J Ophthalmol 2000;84:1061-1063.